Inactivation of PRMT5 by PARP Inhibitors Confers High Susceptibility in MTAP-Deficient Cancers. - Liu, Qi; Sheng, Yuling; Lin, Folan; Tan, Haoyuan; Chang, Yanyun; Lu, Xiaopeng; Chen, Hao; Du, Changzheng (Cancers, 2026)